Report Detail

Pharma & Healthcare Global Insulin Syringes Market Insights, Forecast to 2025

  • RnM2700454
  • |
  • 04 June, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.
The major factors that fuel the growth of the market are the rising aging population and increasing number of diabetic patients globally. In addition, increasing incidence of obesity and people adopting an unhealthy lifestyle supplement the market growth.
The global Insulin Syringes market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin Syringes market based on company, product type, end user and key regions.

This report studies the global market size of Insulin Syringes in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Syringes in these regions.
This research report categorizes the global Insulin Syringes market by top players/brands, region, type and end user. This report also studies the global Insulin Syringes market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD

Market size by Product
3/10 cc syringe
1/2 cc syringe
1 cc syringe
Others
Market size by End User
Hospital
Homecare
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Insulin Syringes market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insulin Syringes market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insulin Syringes companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insulin Syringes submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin Syringes are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Syringes market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Insulin Syringes Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Insulin Syringes Market Size Growth Rate by Product
      • 1.4.2 3/10 cc syringe
      • 1.4.3 1/2 cc syringe
      • 1.4.4 1 cc syringe
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Insulin Syringes Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Homecare
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Insulin Syringes Market Size
      • 2.1.1 Global Insulin Syringes Revenue 2014-2025
      • 2.1.2 Global Insulin Syringes Sales 2014-2025
    • 2.2 Insulin Syringes Growth Rate by Regions
      • 2.2.1 Global Insulin Syringes Sales by Regions
      • 2.2.2 Global Insulin Syringes Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Insulin Syringes Sales by Manufacturers
      • 3.1.1 Insulin Syringes Sales by Manufacturers
      • 3.1.2 Insulin Syringes Sales Market Share by Manufacturers
      • 3.1.3 Global Insulin Syringes Market Concentration Ratio (CR5 and HHI)
    • 3.2 Insulin Syringes Revenue by Manufacturers
      • 3.2.1 Insulin Syringes Revenue by Manufacturers (2014-2019)
      • 3.2.2 Insulin Syringes Revenue Share by Manufacturers (2014-2019)
    • 3.3 Insulin Syringes Price by Manufacturers
    • 3.4 Insulin Syringes Manufacturing Base Distribution, Product Types
      • 3.4.1 Insulin Syringes Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Insulin Syringes Product Type
      • 3.4.3 Date of International Manufacturers Enter into Insulin Syringes Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Insulin Syringes Sales by Product
    • 4.2 Global Insulin Syringes Revenue by Product
    • 4.3 Insulin Syringes Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Insulin Syringes Breakdown Data by End User

    6 North America

    • 6.1 North America Insulin Syringes by Countries
      • 6.1.1 North America Insulin Syringes Sales by Countries
      • 6.1.2 North America Insulin Syringes Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Insulin Syringes by Product
    • 6.3 North America Insulin Syringes by End User

    7 Europe

    • 7.1 Europe Insulin Syringes by Countries
      • 7.1.1 Europe Insulin Syringes Sales by Countries
      • 7.1.2 Europe Insulin Syringes Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Insulin Syringes by Product
    • 7.3 Europe Insulin Syringes by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Insulin Syringes by Countries
      • 8.1.1 Asia Pacific Insulin Syringes Sales by Countries
      • 8.1.2 Asia Pacific Insulin Syringes Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Insulin Syringes by Product
    • 8.3 Asia Pacific Insulin Syringes by End User

    9 Central & South America

    • 9.1 Central & South America Insulin Syringes by Countries
      • 9.1.1 Central & South America Insulin Syringes Sales by Countries
      • 9.1.2 Central & South America Insulin Syringes Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Insulin Syringes by Product
    • 9.3 Central & South America Insulin Syringes by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Insulin Syringes by Countries
      • 10.1.1 Middle East and Africa Insulin Syringes Sales by Countries
      • 10.1.2 Middle East and Africa Insulin Syringes Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Insulin Syringes by Product
    • 10.3 Middle East and Africa Insulin Syringes by End User

    11 Company Profiles

    • 11.1 Novo Nordisk
      • 11.1.1 Novo Nordisk Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novo Nordisk Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novo Nordisk Insulin Syringes Products Offered
      • 11.1.5 Novo Nordisk Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Insulin Syringes Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 Eli Lilly and Company
      • 11.3.1 Eli Lilly and Company Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Eli Lilly and Company Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Eli Lilly and Company Insulin Syringes Products Offered
      • 11.3.5 Eli Lilly and Company Recent Development
    • 11.4 Biocon Ltd
      • 11.4.1 Biocon Ltd Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Biocon Ltd Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Biocon Ltd Insulin Syringes Products Offered
      • 11.4.5 Biocon Ltd Recent Development
    • 11.5 Ypsomed AG
      • 11.5.1 Ypsomed AG Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Ypsomed AG Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Ypsomed AG Insulin Syringes Products Offered
      • 11.5.5 Ypsomed AG Recent Development
    • 11.6 Wockhardt Ltd
      • 11.6.1 Wockhardt Ltd Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Wockhardt Ltd Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Wockhardt Ltd Insulin Syringes Products Offered
      • 11.6.5 Wockhardt Ltd Recent Development
    • 11.7 Medtronic Plc
      • 11.7.1 Medtronic Plc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Medtronic Plc Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Medtronic Plc Insulin Syringes Products Offered
      • 11.7.5 Medtronic Plc Recent Development
    • 11.8 Abbott Laboratories
      • 11.8.1 Abbott Laboratories Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Abbott Laboratories Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Abbott Laboratories Insulin Syringes Products Offered
      • 11.8.5 Abbott Laboratories Recent Development
    • 11.9 Animas Corporation
      • 11.9.1 Animas Corporation Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Animas Corporation Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Animas Corporation Insulin Syringes Products Offered
      • 11.9.5 Animas Corporation Recent Development
    • 11.10 F. Hoffmann-La Roche
      • 11.10.1 F. Hoffmann-La Roche Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 F. Hoffmann-La Roche Insulin Syringes Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 F. Hoffmann-La Roche Insulin Syringes Products Offered
      • 11.10.5 F. Hoffmann-La Roche Recent Development
    • 11.11 BD

    12 Future Forecast

    • 12.1 Insulin Syringes Market Forecast by Regions
      • 12.1.1 Global Insulin Syringes Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Insulin Syringes Revenue Forecast by Regions 2019-2025
    • 12.2 Insulin Syringes Market Forecast by Product
      • 12.2.1 Global Insulin Syringes Sales Forecast by Product 2019-2025
      • 12.2.2 Global Insulin Syringes Revenue Forecast by Product 2019-2025
    • 12.3 Insulin Syringes Market Forecast by End User
    • 12.4 North America Insulin Syringes Forecast
    • 12.5 Europe Insulin Syringes Forecast
    • 12.6 Asia Pacific Insulin Syringes Forecast
    • 12.7 Central & South America Insulin Syringes Forecast
    • 12.8 Middle East and Africa Insulin Syringes Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Insulin Syringes Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Insulin Syringes . Industry analysis & Market Report on Insulin Syringes is a syndicated market report, published as Global Insulin Syringes Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Insulin Syringes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,108.30
      4,662.45
      6,216.60
      3,623.10
      5,434.65
      7,246.20
      596,427.00
      894,640.50
      1,192,854.00
      325,338.00
      488,007.00
      650,676.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report